Article
Riluzole treatment paradoxically increases motoneuron excitability in ALS due to hyperactive homeostasis
2026-03-25
Abstract excerpt
<h4>ABSTRACT</h4> Riluzole is the most commonly prescribed among the limited approved therapies for amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder characterized by progressive motoneuron loss and paralysis. It is thought to act by suppressing motoneuron excitability and glutamate release, but its clinical benefits are modest and often diminish over time. We previously showed that homeostatic me...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 96ae28fa-4c2b-5999-a500-aa0b21f0bf09
- DOI
- 10.64898/2026.03.23.713695
